RxDoctor Payments Data

Nicholas Snavely, MD

MOHS-Micrographic Surgery · Austin, TXNPI 1801099460

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 186 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 26.0% of the total.

$3,944in general payments, 2019–2025

Across 186 payments — averaging $21.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Kerecis Limited$448
  • Johnson & Johnson$426
  • Lilly USA, LLC$260
  • LEO Pharma Inc.$218
  • Sun Pharmaceutical Industries Inc.$195
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$3,944100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,944 in reported general payments places this provider in the 70th percentile of 109 mohs-micrographic surgery providers in Texas.

See all mohs-micrographic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$697,701
Medicare patients
532
Services billed
1,736

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin215$1,495
Doxycycline Hyclate71$436
Cephalexin93$313
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim33$184
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen46$171
Clindamycin Hcl22$153
Amoxicillin29$31

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →